惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Hugging Face - Blog
Hugging Face - Blog
Google DeepMind News
Google DeepMind News
云风的 BLOG
云风的 BLOG
WordPress大学
WordPress大学
Vercel News
Vercel News
Apple Machine Learning Research
Apple Machine Learning Research
T
Tailwind CSS Blog
I
InfoQ
小众软件
小众软件
Recent Announcements
Recent Announcements
博客园 - 【当耐特】
The GitHub Blog
The GitHub Blog
大猫的无限游戏
大猫的无限游戏
美团技术团队
T
The Blog of Author Tim Ferriss
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
酷 壳 – CoolShell
酷 壳 – CoolShell
MongoDB | Blog
MongoDB | Blog
V
V2EX
J
Java Code Geeks
有赞技术团队
有赞技术团队
博客园 - 聂微东
B
Blog RSS Feed
博客园 - 司徒正美

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Globus Medical, Inc. (GMED) Q1 2026 Earnings Call Transcript
2026-05-08 · via All Articles on Seeking Alpha

Globus Medical, Inc. (GMED) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDT

Company Participants

Brian Kearns - Senior Vice President of Business Development & Investor Relations
Keith Pfeil - CEO, President & Director
Kyle Kline - Senior VP & CFO

Conference Call Participants

Shagun Singh Chadha - RBC Capital Markets, Research Division
Matthew Taylor - Jefferies LLC, Research Division
Matthew Miksic - Barclays Bank PLC, Research Division
Richard Newitter - Truist Securities, Inc., Research Division
Ryan Zimmerman - BTIG, LLC, Research Division
David Saxon - Needham & Company, LLC, Research Division
Caitlin Roberts - Canaccord Genuity Corp., Research Division
Thomas Stephan - Stifel, Nicolaus & Company, Incorporated, Research Division
Anna Runci - Piper Sandler & Co., Research Division
Andrew Ranieri - TD Cowen, Research Division

Presentation

Operator

Welcome to Globus Medical's First Quarter 2026 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.

I will now turn the call over to Brian Kearns, Senior Vice President of Business Development and Investor Relations. Mr. Kearns, please go ahead.

Brian Kearns
Senior Vice President of Business Development & Investor Relations

Thank you, Kathy, and thank you, everyone, for being with us today. Joining today's call from Globus Medical will be Keith Pfeil, President and CEO; and Kyle Klin, Chief Financial Officer. This review is being made available via webcast accessible through the Investor Relations section of the Globus Medical website at www.globusmedical.com.

Before we begin, let me remind you that some of the statements made during this review are or may be considered forward-looking statements. Our Form 10-K for the 2025 fiscal year and our subsequent filings with the Securities and Exchange Commission identify certain factors that could cause our actual results to differ materially from those projected in any forward-looking statements made today. Our SEC filings, including the 10-K, are available on our website.